Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
REVENUES, net $ 104,574 $ 142,813
COST OF GOODS SOLD 38,378 62,995
GROSS PROFIT 66,196 79,818
OPERATING EXPENSES:    
Salaries and wages 286,883 373,292
Professional fees 190,447 222,316
Selling, general, and administrative expenses 119,561 168,413
Stock based compensation 144,062 177,813
Research and development 88,237 35,282
Depreciation and amortization 8,318 8,733
Total operating expenses 837,508 985,849
Loss from operations (771,312) (906,031)
OTHER INCOME (EXPENSE):    
Change in fair value of derivative liability (176,998) (3,667)
Gain on modification of debt instruments 3,272 354,791
Loss on abandonment of patents (4,690)
Interest expense (438,285) (447,961)
Gain on sale of assets 5,895
Total other income (expense), net (610,806) (96,837)
Loss before the provision for income taxes (1,382,118) (1,002,868)
PROVISION FOR INCOME TAXES
NET LOSS $ (1,382,118) $ (1,002,868)
NET LOSS PER SHARE    
Basic $ (1.74) $ (1.43)
Diluted $ (1.74) $ (1.43)
SHARES USED IN CALCULATION OF NET LOSS PER SHARE    
Basic 794,183 700,879
Diluted 794,183 700,879